The classification accuracy of the Portland digit recognition test (PDRT) in detecting cognitive malingering was studied in patients claiming cognitive deficits due to exposure to environmental or industrial toxins. Twenty-nine patients alleging toxic exposure and (1999). Diagnostic criteria for malingering neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13, 545-561] criteria for malingered neurocognitive dysfunction were compared to 14 toxic exposure patients negative for evidence of malingering. The published cutoffs were associated with a false positive error rate of 0% and sensitivity of more than 50%. When criterion for a PDRT failure was a positive PDRT finding on more than one section, the FP rate remained 0% while sensitivity improved to about 70%. The results indicate that a failed PDRT is an indication of malingering and not the neurological effect of a toxic substance or some other clinical phenomenon. The PDRT can be used with confidence as an indicator of negative response bias in cases of alleged exposure to neurotoxic substances.
Wekking, & Deelman, 2006; Van Hout, Schmand, Wekking, Hageman, & Deelman, 2003) and Greve et al. (2006a) suggest a similar range.
Appropriate assessment of patients claiming cognitive impairment due to toxic exposure requires the assessment of potential malingering and the development of scientifically based techniques with which to identify malingering patients. Recent research (Greve et al., 2006b (Greve et al., , 2007 with the Test of Memory Malingering (Tombaugh, 1996) , a stand-alone, forced-choice symptom validity test (SVT), and Reliable Digit Span (RDS; Greiffenstein, Baker, & Gola, 1994) , an "embedded" clinical indicator of malingering, indicates that malingering in persons claiming cognitive deficits attributable to toxic exposure can be accurately identified. Moreover, these studies suggest that data from malingering detection studies in traumatic brain injury (TBI) can be reasonably applied to toxic exposure cases.
The Portland Digit Recognition Test (PDRT; Binder & Willis, 1991; Binder, 1993a Binder, , 1993b , is one of the first formally developed forced-choice symptom validity tests (SVT; and is still in common use (Slick, Tan, Strauss, & Hultsch, 2004) . The PDRT is a 72-item SVT employing visual recognition of orally presented five-digit number strings (Binder, 1990 (Binder, , 1993a . The 72 items are divided into two sets of 36 items: the first 36 trials are referred to as the "Easy" items and the second 36 are the "Hard" items based on their apparent difficulty.
The published cutoffs (Binder & Willis, 1991; Binder, 1993a) for the easy, hard and total items sets are associated with a 0% false positive error (FP) rate (100% specificity) in non-compensation-seeking patients with objective evidence of brain damage (Binder & Kelly, 1996) . Ju and Varney (2000) reported a false positive error rate of 8-10% for the full test in a similar sample. Bianchini, Mathias, Greve, Houston, and Crouch (2001) reported specificity of 100% for the published cutoffs in a group of non-compensation-seeking TBI patients who had mostly suffered moderate-severe injuries. These findings were replicated by who also reported classification accuracy data at a range of cut scores. Sensitivity at cutoffs associated with conservative FP rates (e.g., 0-5%) ranged from about 25% up to about 70% in TBI.
Purpose
The purpose of this study is to use a known-groups design to determine the classification accuracy of the PDRT in persons alleging toxic exposure. The Slick et al. (1999) criteria and well-validated malingering indicators were used to classify patients as malingering or not malingering. Only psychometric indicators of malingering which have been validated in traumatic brain injury patient groups which included persons with objectively documented brain damage (e.g., positive neuroradiological findings) were used. By only using data from studies that included persons with documented brain damage in the non-malingering groups, we reduce the risk of false positive errors in persons exposed to substances with well-documented neurotoxic properties (e.g., carbon monoxide).
Method

Participants
Toxic exposure
PDRT data were collected from the files of 133 persons referred for neuropsychological evaluation related to alleged exposure to environmental and industrial substances. The 71 persons who were not administered the PDRT and the two who completed an abbreviated PDRT were excluded. All data were archival and were collected over the past 10 years from a single clinical psychology practice in a Southeastern metropolitan area. Table 1 lists the substances to which these patients were exposed. Some of these substances have no neurotoxic properties (e.g., helium, clonazepam, mold). Others may indirectly result in neurological damage, usually via hypoxia secondary to pulmonary damage (e.g., hydrochloric acid, chlorine gas, mustard gas). Still others (e.g., carbon monoxide, lead, organic solvents) can have direct neurotoxic properties. In most cases, the degree of exposure was determined insufficient to produce significant brain dysfunction and/or there was no objective evidence of brain pathology. However, because some patients did have clinically meaningful neurotoxic exposures, psychometric criteria contributing to the diagnosis of malingering are based on the performance of samples which include patients with objectively defined brain pathology (see above). All included patients had external incentive in the form of a workers compensation and/or personal injury claim. The patients were classified into one of three groups (see details of the classification methodology in the following section). The malingering group (MND; n = 29) was comprised of all patients meeting Slick et al. criteria for probable (n = 27) or definite MND (n = 2). The non-malingering group (Not MND; n = 14) was comprised of patients with evidence of external incentive (n = 14) who met none of the Slick et al. criteria (except the presence of external incentive) and were negative on all psychometric malingering indicators. Patients were included in the Not MND group only if they completed at least the Reliable Digit Span test and the MMPI-2. Almost all completed at least one other formal symptom validity test (the TOMM and/or Word Memory Test, which was only used to exclude patients from the Not MND group) as well as other clinical tests containing derived indicators of malingering (e.g., California Verbal Learning Test, Wisconsin Card Sorting Test). Seventeen patients did not meet criteria for the MND group but did show evidence of negative response bias (Indeterminate group) and were thus excluded from the classification accuracy analysis because of the ambiguity of their malingering status.
Malingering classification method
Patients were categorized on the basis of the Slick et al. (1999) criteria for Malingered Neurocognitive Dysfunction (MND) using a diagnostic decision tree similar to the one presented by Millis (2004) . In determining the presence of MND, the case must be evaluated on the basis of four criteria: (A) presence of substantial external incentive; (B) evidence from neuropsychological testing; (C) evidence from self-report; (D) behaviors meeting the necessary B and C criteria are not fully accounted for by psychiatric, neurological, or developmental factors. Using this system, all diagnoses of malingering require the presence of external incentive (criterion A) plus criterion B and/or C evidence as noted below. Criterion B behaviors, in the context of external incentive, are sufficient for a diagnosis of malingering on their own.
Evidence from criterion B may include discrepancies between test data and known patterns of brain functioning (B3), behavioral observations (B4), information from collaterals (B5), and documented history (B6). However, the most powerful criterion B evidence is documentation of negative response bias on the basis of performance on a forced-choice symptom validity test (SVT; see Bianchini, Mathias, Greve, Houston et al., 2001 , for a review of these measures). Performance on a forced-choice measure can indicate either "definite" response bias (B1: obtained score is significantly below chance at alpha < .05, two-tailed) or "probable" response bias (B2: obtained score on a well-validated measure of response bias is in a range consistent with exaggeration or feigning). Other "malingering" tests and indices from standard clinical measures can also meet B2.
Criterion C behaviors include discrepancies between self-report and documented history (C1), known patterns of brain functioning (C2), behavioral observations (C3), and information from collaterals (C4). This criterion (C5) includes evidence of exaggeration or fabrication of psychological symptoms on self-report measures with well-validated validity scales (e.g., MMPI-2). Criterion C indicators are considered evidence of possible malingering but are insufficient on their own for a diagnosis of malingering.
A B1 finding is sufficient for a diagnosis of "definite MND". A diagnosis of "probable MND" can be made with two types of criterion B evidence or one type of criterion B evidence and one or more types of criterion C evidence. Criterion C evidence is not sufficient for a diagnosis in the absence of criterion B evidence. "Possible MND" is diagnosed when the criteria for "probable MND" have been met but criterion D factors are present.
For purposes of this study, criterion B2 could be met on the basis of a positive finding on any of the following: (1) Test Of Memory Malingering (TOMM; Tombaugh, 1996) ; (2) Reliable Digit Span (RDS; Greiffenstein et al., 1994) ; (3) Millis formula for the California Verbal Learning Test (CVLT; Millis, Putnam, Adams, & Ricker, 1995) ; (4) CVLT model average (Millis & Volinsky, 2001) . A positive finding was any score greater than or equal to the 1% false positive (FP) error level for the TOMM (Greve, Bianchini, & Doane, 2006) , RDS (Heinly, Greve, Bianchini, Love, & Brennan, 2005) , and CVLT indicators (Curtis, Greve, Bianchini, & Brennan, 2006) based on the performance of all non-malingering TBI patients. Criterion B3 (deviation from known patterns of brain functioning) was met on the basis a difference between WMS-R general memory > attention & concentration (Mittenberg, Azrin, Millsaps, & Heilbronner, 1993 ) at the 5% FP error level reported by (Hilsabeck et al., 2001) .
Criterion B6 (test performance worse than documented history) was based on at least two of the following from the WAIS-III: Letter-Number Sequencing, Digit Symbol-Coding, Arithmetic, Symbol Search; OR, Processing Speed Index (PSI), Arithmetic, Letter-Number Sequencing. Cutoffs were at the 6% FP level for moderate severe TBI for Digit Symbol and Letter-Number Sequencing (Etherton, Bianchini, Ciota, Heinly, & Greve, 2006) and PSI and Symbol Search . Because of the nature of the distribution, the 3% FP level was used for Arithmetic (Etherton, Bianchini, Ciota et al., 2006) . B6 would also be met with three or more Wechsler Memory Scale-III index scores of less than 75 (Ord, Greve, & Bianchini, in press ). Criterion C5 could be met on the basis of MMPI-2 F, Fb, and FBS scores. Cutoffs for F and Fb were at the 5% FP error level (Greve, Bianchini, Love, Brennan, & Heinly, 2006) for all TBI patients; for FBS, the 1% FP level was used. Specific cut-offs can be obtained from the authors on request.
Results
Sample characteristics
The toxic exposure patients averaged 52.2 months between injury and evaluation (S.D. = 28.3) and there was no difference in time post-injury among the non-malingering, malingering, and indeterminate groups (F [2, 54] = 1.10, p = ns, eta 2 = .04). Time post-injury could not be found for five (8.1%) patients. There were also no group differences in age (grand mean = 41.9, S.D. = 11.2; F [2, 57] = 2.00, p < ns, eta 2 = .07) or education (grand mean = 12.0, S.D. = 2.7; F [2, 57] = 1.71, p = ns, eta 2 < .06). Similarly, there were no gender (81.7% male) or race differences (Caucasian = 50.0%; African-American = 34.5%; Asian = 1.7%; not indicated = 13.8%) across groups. By definition, none of the Not MND patients were positive on any of the psychometric indicators of malingering. In contrast, of the MND patients, 100% were positive on B1/B2, 51.4% on B3 or B6, and 92.6% on C5. Among the indeterminate group, 17.6% were positive on B1/B2, 15.4% on B3 or B6, and 69.2% on C5. 
Malingering group analyses
The PDRT scores were submitted to a multivariate analysis of variance (MANOVA) followed by univariate analyses of variance (ANOVA) to examine group effects. The means for each of the three groups (Not malingering, indeterminate, and malingering) are presented in Table 2 . Significant group effects were observed for each PDRT trial (analysis results are presented in Table 2 ). Post hoc testing demonstrated that the Not MND and indeterminate groups did not significantly differ. The MND group produced significantly lower scores. At a group level the PDRT differentiated between MND and Not MND toxic exposure claimants.
Receiver operation characteristics analysis
An ROC analysis examines the overall classification accuracy of a test. Table 3 presents areas under the curve (AUC), standard error, and 95% confidence intervals (CI) for the toxic exposure sample (Not MND and MND, excluding the indeterminate group). Points on the ROC curves are based on the ratio of sensitivity (hit rate) to 1− specificity (false positive error rate) and reflect the degree to which the two groups are differentiated at all possible score levels. The three PDRT scores significantly differentiated MND from Not MND patients. Overall, this analysis further demonstrates that the PDRT accurately differentiates MND from Not MND toxic exposure claimants.
Classification accuracy
The ROC analysis is a good way to compare overall classification accuracy of diagnostic tests. However, it does not address the accuracy of the tests at specific cutoffs. Even when overall classification accuracy is equal, the choice of cutoffs can have an important impact on the resulting type of classification error. This section, therefore, examines the classification accuracy of the PDRT scores at a range of cutoffs. Tables 4 and 5 present the false positive error rates, sensitivity, and likelihood ratio (LR) across a range of score levels for the easy, hard, and total PDRT. LR is the ratio of sensitivity to false positive error rate and reflects the likelihood that a positive test result will occur in the malingering sample compared to the non-malingering sample and. The data from the TBI patients of Binder and Kelly (1996) and , mostly moderate-severe cases and all without external incentive, are presented for comparison. Table 4 Cumulative percentages of patients with scores equal to or lower than the indicated raw score for the PDRT "easy" and "hard" items LR: likelihood ratio; MND: malingered neurocognitive dysfunction. a TBI patients (predominantly moderate-severe) with no external incentive from . b Mixed neurological patients with objective evidence of brain damage or dysfunction with no external incentive from Binder and Kelly (1996) .
As can be seen, the false positive error rates of the PDRT in toxic exposure are comparable to those seen in moderate-severe TBI. In no case do the Not Malingering toxic exposure patients perform beyond the original published cutoffs represented by the 0% FP cutoff of the Binder and Kelly (1996) data. Both the FP rate and sensitivity for these toxic exposure patients is comparable to those reported by for mixed mild and moderatesevere TBI patients (comparison based on cutoffs associated with a 5% FP rate in the combined non-malingering TBI sample). In fact, LR is maximized at these cutoffs, with malingering toxic exposure patients being about 10 times more likely to be positive on PDRT easy and hard items and about six times more likely on the totals score compared to Not malingering toxic exposures patients. Thus, at the individual level, the PDRT accurately differentiates malingerers from non-malingerers.
Joint classification accuracy
The following section examines the classification accuracy of the PDRT as a whole, rather than as individual subtests. Four sets of cutoffs tied to false positive error rates of 0%, 2%, 5%, and 10% based on the Binder and Kelly (1996) data were examined. The 0% FP cutoffs are the originally published cut scores. Table 6 presents these specific cutting scores and the associated FP rate, sensitivity, and LR for the present sample. This part of the table essentially reproduces data in Tables 4 and 5 . Next is presented the percentage of "failed" PDRT's based on failure of one or more, two or more, or all three subtests or sections.
These data show that at the 0% FP cutoffs, the PDRT correctly detects 65% of malingerers without any failures among the non-malingerers. At the 2% cutoffs, a positive finding on any two subtests correctly detects 72% of malingerers, again without any failures among the non-malingerers. At the 5% and 10% cutoffs, sensitivity drops to the upper 50% range when all three tests are positive while still maintaining a FP error rate of 0%. This means that the clinician can be Table 5 Cumulative percentages of patients with scores equal to or lower than the indicated raw score for the Total PDRT score LR: likelihood ratio; MND: malingered neurocognitive dysfunction. a TBI patients (predominantly moderate-severe) with no external incentive from . b Mixed neurological patients with objective evidence of brain damage or dysfunction with no external incentive from Binder and Kelly (1996) . quite confident in concluding that a patient is showing negative response bias when the PDRT is failed at the published cutoffs. However, one can be similarly confident when there are multiple failures at less extreme cutoffs.
Discussion
The purpose of this study was to determine the classification accuracy of the PDRT in the detection of cognitive malingering in persons claiming deficits due to exposure to environmental and industrial toxins. Recent research suggests that malingering is a significant problem that has gone relatively unaddressed until recently. Only a few malingering indicators have been validated in this population. The present results replicate the PDRT findings in traumatic brain injury.
Specifically, the original published PDRT cutoffs are associated with a false positive error rate of 0% in this study, just as has been seen in even moderate-severe TBI and mixed neurological patients with objective evidence of brain damage or dysfunction (Binder & Kelly, 1996) . That means that only persons classified as malingering using a published diagnostic system failed the PDRT at that level. Like the previous studies in TBI, this study demonstrated that the published cutoffs are actually quite conservative. The FP rate at less conservative cutoffs remained 0% when criterion for a PDRT failure was a positive finding on more than one section of the PDRT.
Interestingly, under those circumstances, sensitivity was enhanced relative to the original cut scores. For example, the failure of at least two PDRT sections at the 2% cutoff was associated with a 0% FP rate and detected 72% of malingerers. A single positive test at the original cutoff detected 65%. Beyond the 2% level (i.e., 5% and 10% FP cutoffs), an overall FP rate of 0% was obtained with three of three positive tests but only detected between 55% and 59% of malingerers. Thus, requiring multiple hits at less conservative cutoffs actually resulted in a loss of sensitivity.
The present findings are consistent with those of Greve, Ord, Curtis, Bianchini, and Brennan (in press) who reported data on the joint use of multiple SVTs including the PDRT and with Larrabee (2003) who examined joint classification multiple indicators including SVTs and embedded indicators. This means that not only can the clinician be confident in the meaning of a positive finding on the PDRT in toxic exposure, they can be confident of its meaning in the context of findings from other stand-alone SVTs and embedded indicators (e.g., Reliable Digit Span, Greve et al., 2007) . This is particularly important since current recommendations encourage the use of multiple methods of detecting malingering in neuropsychological evaluations (Bush et al., 2005; Sweet & King, 2002) . A limitation of the present study is the small sample size, particularly in the Not MND group, and of the method by which malingering was ruled out. More sophisticated classification methods are available (see Greve et al., in press ). However, the use of such a method would likely reduce the Not MND sample even further. The present method is conservative because misclassification, if it occurs, is most likely to be in the Not MND group. That is, patients giving poor effort are more likely to be included in the Not MND group. The MND group likely contains few misclassified cases since the psychometric cutoffs are conservative. An additional reason for using this method is that it is essentially the same as in previous papers on malingering detection in toxic exposure (Greve et al., 2006b (Greve et al., , 2007 , so there is consistency across studies. More importantly, even using this less sophisticated method and with the smaller sample size, the results are robust not just for the PDRT but also for the TOMM and RDS and the findings for all three indicators are consistent with previous studies.
In summary, the current findings for the PDRT in toxic exposure indicate that scores below the published cutoffs are associated with a 0% FP rate while detecting two thirds of patients who were malingering. These findings are consistent with those reported in TBI. Even multiple positive findings at less extreme cutoffs are associated with a 0 FP rate and may have a slightly higher sensitivity. Taken together, studies of the PDRT mean that one can be confident that a positive PDRT finding reflects negative response bias and not the neurological effect of a toxic substance or some other clinical phenomenon (e.g., psychiatric disturbance). In short, the PDRT can be used with confidence as one indicator of negative response bias and intentional poor performance in cases of cognitive deficits attributed to exposure to alleged neurotoxic substances.
